Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study

[1]  Nicolas A. Menzies,et al.  Bayesian Methods for Calibrating Health Policy Models: A Tutorial , 2017, PharmacoEconomics.

[2]  Richard G. White,et al.  Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. , 2016, The Lancet. Global health.

[3]  T. Cohen,et al.  High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions , 2016, European Respiratory Journal.

[4]  E. Vynnycky,et al.  The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study , 2016, BMC Medicine.

[5]  Christopher Gilpin,et al.  WHO's new End TB Strategy , 2015, The Lancet.

[6]  P. V. van Helden,et al.  The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  R. Chaisson,et al.  A trial of mass isoniazid preventive therapy for tuberculosis control. , 2014, The New England journal of medicine.

[8]  R. Hayes,et al.  Effect of household and community interventions on the burden of tuberculosis in southern Africa: the ZAMSTAR community-randomised trial , 2013, The Lancet.

[9]  Radhika Dhingra,et al.  Sensitivity analysis of infectious disease models: methods, advances and their application , 2013, Journal of The Royal Society Interface.

[10]  P. V. van Helden,et al.  High Prevalence of Tuberculosis and Insufficient Case Detection in Two Communities in the Western Cape, South Africa , 2013, PloS one.

[11]  C. Dye,et al.  The impact of new tuberculosis diagnostics on transmission: why context matters. , 2012, Bulletin of the World Health Organization.

[12]  N. Beyers,et al.  The Rate of Sputum Smear-Positive Tuberculosis after Treatment Default in a High-Burden Setting: A Retrospective Cohort Study , 2012, PloS one.

[13]  P. Sonnenberg,et al.  High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis. , 2010, The Journal of infectious diseases.

[14]  R. Hayes,et al.  Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  C. Sismanidis,et al.  Prevalence of Tuberculosis, HIV and Respiratory Symptoms in Two Zambian Communities: Implications for Tuberculosis Control in the Era of HIV , 2009, PloS one.

[16]  R. Chaisson,et al.  The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection. , 2009, Bulletin of the World Health Organization.

[17]  Christopher Dye,et al.  Mathematical models of the epidemiology and control of drug-resistant TB , 2009, Expert review of respiratory medicine.

[18]  J. Golub,et al.  Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. , 2007, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  E. Bateman,et al.  High Prevalence of Tuberculosis in Previously Treated Patients, Cape Town, South Africa , 2007, Emerging infectious diseases.

[20]  Ted Cohen,et al.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission , 2007, Journal of The Royal Society Interface.

[21]  Marc Lipsitch,et al.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Dye,et al.  Tuberculosis control in the era of HIV , 2005, Nature Reviews Immunology.

[23]  R. Wallis.  Reconsidering adjuvant immunotherapy for tuberculosis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Donald A Enarson,et al.  Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. , 2005, American journal of respiratory and critical care medicine.

[25]  R. Chaisson,et al.  Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? , 2003, AIDS.

[26]  A. Harries,et al.  Preventing recurrent tuberculosis in high HIV-prevalent areas in sub-Saharan Africa: what are the options for tuberculosis control programmes? , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[27]  Epco Hasker,et al.  Recurrence in tuberculosis: relapse or reinfection? , 2003, The Lancet. Infectious diseases.

[28]  P. Sonnenberg,et al.  HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers , 2001, The Lancet.

[29]  C. Dye,et al.  Will tuberculosis become resistant to all antibiotics? , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[30]  M. Desvarieux,et al.  Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial , 2000, The Lancet.

[31]  B G Williams,et al.  Criteria for the control of drug-resistant tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P D van Helden,et al.  Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. , 1999, The New England journal of medicine.

[33]  Christopher Dye,et al.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy , 1998, The Lancet.

[34]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[35]  G. Schoolnik,et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. , 1992, The New England journal of medicine.

[36]  C. Dolea,et al.  World Health Organization , 1949, International Organization.